Intelligent Feline Health Management System
Legal Citation
Summary of the Inventive Concept
A synergistic system combining a sulfonated polystyrene derivative with AI, IoT, blockchain, and novel materials to treat and prevent cat flu, providing enhanced diagnostic capabilities, personalized treatment, and predictive analytics.
Background and Problem Solved
The original patent disclosed a sulfonated polystyrene derivative for treating cat flu, but it had limitations in terms of diagnostic accuracy, treatment effectiveness, and data management. The new inventive concept addresses these limitations by integrating the derivative with advanced technologies to create a comprehensive feline health management system.
Detailed Description of the Inventive Concept
The system comprises a sulfonated polystyrene derivative of formula I, an AI-powered diagnostic module for identifying feline calicivirus or feline herpesvirus infections, IoT-enabled sensors for tracking vital signs and symptoms, a blockchain-based data storage system for secure and transparent data management, and novel, biodegradable materials for controlled release of the derivative. The system enables personalized treatment, predictive analytics, and real-time monitoring of treatment effectiveness.
Novelty and Inventive Step
The new claims introduce a synergistic combination of the sulfonated polystyrene derivative with AI, IoT, blockchain, and novel materials, which provides a non-obvious and innovative solution for feline health management. The integration of these technologies enables a level of diagnostic accuracy, treatment effectiveness, and data management that is not achievable with the original patent alone.
Alternative Embodiments and Variations
Alternative embodiments of the system could include the use of different AI algorithms, varying IoT sensor configurations, or alternative blockchain platforms. Additionally, the system could be adapted for use in other animal species or human health applications.
Potential Commercial Applications and Market
The Intelligent Feline Health Management System has significant commercial potential in the veterinary and animal health industries, with potential applications in pet care, animal research, and public health. The system's advanced diagnostic capabilities, personalized treatment, and predictive analytics make it an attractive solution for pet owners, veterinarians, and researchers.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Veterinary pharmaceuticals, biotechnology, and digital health technologies with a focus on infectious disease management in companion animals
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in veterinary medicine, biotechnology, or biomedical engineering, possessing expertise in pharmaceutical formulations, diagnostic technologies, and digital health systems
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with existing pharmaceutical treatments represents a predictable and logical extension of current medical management strategies. The combination of a known sulfonated polystyrene derivative for cat flu treatment with AI, IoT, and blockchain technologies follows established patterns of digital transformation in healthcare. The technical variations represent incremental improvements that leverage standard technological integration techniques.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,566 |
|---|---|
| Title | Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu |
| Assignee(s) | UNIWERSYTET JAGIELLONSKI |